Table 1.
Clinical features | Total | circRNA_101237 | p-vaule | |
---|---|---|---|---|
High (N = 153) | Low (N = 150) | |||
Age (years) | 0.252 | |||
<60 | 90 | 50 | 40 | |
≥60 | 213 | 103 | 110 | |
Gender | 0.154 | |||
Male | 170 | 92 | 78 | |
Female | 133 | 61 | 72 | |
Smoke | 0.232 | |||
No | 68 | 30 | 38 | |
Yes | 235 | 123 | 112 | |
Drink | 0.118 | |||
No | 143 | 79 | 64 | |
Yes | 160 | 74 | 86 | |
Tumor size (cm) | 0.044 | |||
<5 | 122 | 53 | 69 | |
≥5 | 181 | 100 | 81 | |
Differentiation grade | 0.144 | |||
Well | 101 | 45 | 56 | |
Moderate + Poor | 202 | 108 | 94 | |
TNM stage | 0.001 | |||
I + II | 191 | 83 | 108 | |
III | 112 | 70 | 42 | |
Lymph node metastasis | 0.003 | |||
No | 191 | 84 | 107 | |
Yes | 112 | 69 | 43 | |
CEA, ng/ml | 0.230 | |||
<5 | 145 | 68 | 77 | |
≥5 | 158 | 85 | 73 | |
CA19-9, kU/L | 0.310 | |||
<40 | 128 | 69 | 59 | |
≥40 | 175 | 84 | 91 |
CA19-9 carbohydrate antigen 19-9; CEA, carcinoembryonic antigen; Pearson chi-square test was used for comparison between subgroups.